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Augmented renal clearance in critically ill patients: 
incidence, associated factors and effects on 
vancomycin treatment
ORIGINAL ARTICLE
INTRODUCTION
Critically ill patients frequently develop a hyperdynamic cardiovascular 
pattern as a consequence of systemic inflammatory response. High cardiac 
output could be associated with increased perfusion in different organs, 
including the kidneys. In this way, increases in the glomerular filtration rate 
could ensue, with subsequent enhanced renal elimination of circulating solutes. 
This phenomenon is known as renal hyperfiltration, or augmented renal 
clearance (ARC).(1) The syndrome is commonly defined by an increase in the 
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Objective: An augmented renal 
clearance has been described in some 
groups of critically ill patients, and it 
might induce sub-optimal concentrations 
of drugs eliminated by glomerular 
filtration, mainly antibiotics. Studies on its 
occurrence and determinants are lacking. 
Our goals were to determine the incidence 
and associated factors of augmented renal 
clearance and the effects on vancomycin 
concentrations and dosing in a series of 
intensive care unit patients.
Methods: We prospectively studied 
363 patients admitted during 1 year to 
a clinical-surgical intensive care unit. 
Patients with serum creatinine >1.3mg/dL 
were excluded. Creatinine clearance was 
calculated from a 24-hour urine collection. 
Patients were grouped according 
to the presence of augmented renal 
clearance (creatinine clearance >120mL/
min/1.73m2), and possible risk factors 
were analyzed with bivariate and logistic 
regression analysis. In patients treated 
with vancomycin, dosage and plasma 
concentrations were registered.
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Results: Augmented renal clearance 
was present in 103 patients (28%); they 
were younger (48±15 versus 65±17 
years, p<0.0001), had more frequent 
obstetric (16 versus 7%, p=0.0006) 
and trauma admissions (10 versus 3%, 
p=0.016) and fewer comorbidities. The 
only independent determinants for 
the development of augmented renal 
clearance were age (OR 0.95; p<0.0001; 
95%CI 0.93-0.96) and absence of 
diabetes (OR 0.34; p=0.03; 95%CI 
0.12-0.92). Twelve of the 46 patients who 
received vancomycin had augmented 
renal clearance and despite higher doses, 
had lower concentrations.
Conclusions: In this cohort of 
critically ill patients, augmented renal 
clearance was a common finding. Age 
and absence of diabetes were the only 
independent determinants. Therefore, 
younger and previously healthy patients 
might require larger vancomycin dosing.
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creatinine clearance (ClCr).
(2) In the clinical practice, the 
ClCr is usually estimated with the Cockcroft-Gault formula 
from creatinine plasma concentrations (estimated ClCr), 
instead of calculating it after a 24-hour urine collection 
(24-h ClCr). In critically ill patients, the agreement between 
both methods is poor.(3)
ARC in the critically ill is associated with some 
conditions, mostly trauma(4) and burns.(5) Nevertheless, its 
epidemiology, risk factors, and clinical characteristics have 
not been comprehensively investigated. Particularly, studies 
focused on general populations of critically ill patients are 
scarce. Most importantly, the increase in kidney function 
may decrease plasma concentrations of several drugs, 
involving such relevant therapeutic issues as antibiotic 
dosing.(6) The main concern is a lack of achievement of 
therapeutic concentrations of antimicrobial agents, which 
can lead to both treatment failures and generation of 
resistant bacteria.(7) In this respect, a vancomycin trough 
level <15µg/mL has been identified as an independent 
predictor of treatment failure.(8)
We studied these issues in a cohort of medical/surgical 
critically ill patients. Our objectives were as follows: (1) to 
describe the incidence of ARC on the day of admission; 
(2) to evaluate the ability of estimated ClCr, compared to 
a 24-hour ClCr, to diagnose ARC, as well as the agreement 
between both parameters; (3) to identify predictors 
of ARC; and (4) to assess the impact of ARC on the 
vancomycin plasma concentration and dosage.
METHODS
This is a prospective cohort study in consecutive 
patients admitted to a sixteen-bed mixed medical-surgical 
intensive care unit (ICU) during a period of 1 year, from 
October 1, 2011 to September 31, 2102. The exclusion 
criteria were age under 21 years, refusal to participate in the 
study, not having a bladder catheter in place, unavailable 
24-hour urine collection, and plasma creatinine levels 
>1.3mg/dL. Our study was approved by the Institutional 
Review Board. As standard procedures were applied in the 
diagnosis, permission only to use the data was requested 
from patients or relatives.
On admission, demographic data (age, gender, 
weight, height), and main diagnostic categories (septic, 
postoperative, obstetric, trauma, and neurologic) 
were registered. Throughout the following day, Acute 
Physiological and Chronic Health Evaluation II 
(APACHE II) and Sequential Organ Failure Assessment 
(SOFA) scores, the use of vasopressors, inotropes and 
diuretics, and the input/output of fluids were recorded. 
Additionally, a 24-hour urine sample was collected using 
a bladder catheter.
We measured arterial blood gases, (AVL OMNI 9, 
Roche Diagnostics, Graz, Austria), plasma and urinary 
[Na+], [K+] and [Cl-] (Ion selective electrode, AEROSET, 
Abbott Laboratories, Abbott Park, Illinois, U.S.A), plasma 
albumin concentration (Bromocresol-sulfoftalein), lactate 
(Ion selective electrode, AVL OMNI 9), plasma and 
urinary levels of urea and creatinine (kinetic modification 
of the Jaffé reaction), and urine proteins.
The 24-hour ClCr was calculated according the 
following formula: creatinine clearance (mL/min) = 
[urinary creatinine (mg/dL) x urinary output (mL/
min)]/[plasma creatinine (mg/dL)]. The 24-hour ClCr 
was adjusted to body surface area, estimated according 
to Mosteller:(9) body surface area = √weight (kg) x height 
(cm)/3,600.
The estimated ClCr was calculated from plasma 
creatinine using the Cockcroft-Gault formula.(10)
In patients with suspected or confirmed gram-positive 
infections, vancomycin was initially administered as a 
loading dose (15mg/kg) followed by continuous infusion 
(30mg/kg/day) aimed at plasma concentrations of 
15-25µg/mL.(11) If appropriate, dosage adjustments were 
performed on subsequent days. Daily doses of vancomycin 
were registered, and serum levels were measured on the 
first 3 days of treatment using a homogeneous enzyme 
immunoassay (VITROS VANC, Ortho-Clinical 
Diagnostics, Johnson & Johnson, Rochester, NY, USA).
Statistics
Patients were grouped according to the presence or 
absence of ARC (24-h ClCr ≥120 or <120mL/min/1.73m
2, 
respectively). Data were analyzed for distribution by 
means of Kolmogorov-Smirnov test. Linear regression and 
Bland and Altman analysis were used for the evaluation of 
correlation and agreement between the different methods 
of calculation of ClCr.
(12) Comparisons between groups were 
performed with unpaired Student's t-test for parametric 
variables and Mann-Whitney U-test for non-parametric 
variables. Categorical parameters were compared with 
chi-square test. All variables with a p value <0.20 in 
bivariate analysis were entered in a logistic regression 
analysis with ARC as the outcome variable. Doses and 
plasma concentrations of vancomycin were compared by 
two-way repeated measures of ANOVA. A p value <0.05 
was considered statistically significant.
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RESULTS
Three hundred and sixty-three patients were 
included; 103 (28%) developed ARC. The clinical and 
epidemiological data of both groups are shown in table 1. 
Compared to patients without ARC, those with ARC 
were younger, had obstetric and trauma admissions more 
frequently, and showed lower APACHE II scores. There 
were no differences in SOFA score.
Estimated and 24-hour ClCr were significantly correlated 
but showed poor agreement (Figure 1). Sensitivity and 
specificity of estimated ClCr for the identification of ARC 
were 39.8 and 90.8%, respectively.
Patients with ARC had higher diuretic volumes 
and urinary elimination of electrolytes, and less use of 
furosemide and positive fluid balance. There were no 
differences in acid-base parameters, plasma electrolytes, 
fluid intake, and norepinephrine requirement. The urine 
protein/creatinine ratio was higher in patients without 
ARC (Table 2).
In the linear regression analysis, age and 24-hour 
ClCr were significantly correlated (R
2=0.28, p<0.0001). 
Logistic regression analysis identified younger age and 
absence of diabetes as the only independent predictors of 
ARC (Table 3).
Table 1 - Clinical and epidemiological data in patients with and without augmented renal clearance
Augmented renal clearance (N=103) No augmented renal clearance (N=260) p value
Gender (male) 49 (48) 54 (47) 0.96
Age (years) 48±15 65±17 <0.0001
Height (cm) 168±11 166±10 0.06
Actual weight (kg) 73±17 76±17 0.10
Ideal weight (kg) 62±12 60±11 0.12
Body area (m2) 1.84±0.26 1.86±0.24 0.35
Comorbidities
Hypertension 21 (20) 126 (48) <0.0001
Ischemic cardiopathy 5 (5) 23 (9) 0.20
Cardiac failure 0 (0) 13 (5) 0.0208
Atrial fibrillation 6 (6) 46 (18) 0.0036
Diabetes mellitus 5 (5) 46 (18) 0.0015
COPD 3 (3) 17 (7) 0.1723
Smoking 13 (13) 52 (20) 0.0983
Cancer 33 (32) 87 (33) 0.795
APACHE II score 7 [4-11] 10 [6-14] <0.0001
SOFA score 1 [0-2] 1 [0-3] 0.12
Mechanical ventilation 19 (18) 46 (18) 0.87
Shock 12 (12) 44 (17) 0.21
Diagnostic categories
Postoperative 50 (49) 117 (45) 0.54
Septic 14 (16) 53 (20) 0.13
Obstetric 16 (16) 17 (7) 0.0006
Neurologic 10 (10) 33 (13) 0.43
Trauma 10 (10) 9 (3) 0.016
ICU mortality 4 (4) 20 (8) 0.19
Hospital mortality 4 (4) 20 (8) 0.19
ICU length of stay (days) 2 [1-4] 2 [1-4] 0.87
Hospital length of stay (days) 7 [5-11] 8 [5-15] 0.22
COPD - chronic obstructive pulmonary disease; APACHE II - Acute Physiology And Chronic Health Evaluation II; SOFA - Sequential Organ Failure Assessment; ICU - intensive care unit. Data are 
shown as number (%), mean±SD or median [IQR].
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Figure 1 - Panel A) Linear regression analysis between 24-hour urine-collected creatinine clearance and estimated creatinine clearance. Panel B) Bland and Altman 
analysis between the 24-hour urine-collection creatinine clearance and estimated creatinine clearance. Lines represent the bias and the 95% limits of agreement.
Table 2 - Acid-base and renal parameters in patients with and without augmented renal clearance
Augmented renal clearance (N=103) No augmented renal clearance (N=260) p value
Plasma creatinine (mg/dL) 0.7±0.2 0.9±0.2 <0.0001
Plasma urea (mg/dL) 25±11 34±15 <0.0001
Arterial pH 7.41±0.05 7.41±0.06 0.93
Arterial PCO2 (mmHg) 37±7 38±8 0.65
Arterial PO2 (mmHg) 99±27 93±30 0.12
Arterial [HCO3
-] (mmHg) 23±3 23±4 0.50
Plasma [Na+] (mEq/L) 136±4 136±4 0.78
Plasma [K+] (mEq/L) 3.9±0.4 3.9±0.5 0.21
Plasma [Cl-] (mEq/L) 105±5 104±6 0.33
Lactate (mmol/L) 1.6±0.6 1.7±0.8 0.15
Albumin (g/L) 2.6 ± 0.6 2.6±0.6 0.95
Urinary urea (g/day) 24.8±10.9 18.3±8.8 <0.0001
Urinary creatinine (mg/day) 1605±650 1039±432 <0.0001
24-hour ClCr (mL/min/1,73m2) 155±33 78±25 <0.0001
Estimated ClCr (mL/min) 126±48 80±29 <0.0001
Urinary [Na+] (mEq/day) 255±147 187±129 <0.0001
Urinary [K+] (mEq/day) 84±40 67±29 0.0004
Urinary [Cl-] (mEq/day) 318±160 228±136 <0.0001
Urinary protein (g/day) 0.36 [0.19-0.69] 0.40 [0.22-0.71] 0.46
Infused fluids (mL/24 h) 3093±1104 3342±1508 0.13
Diuresis (mL/24 h) 2446±1337 1924±904 <0.0001
Fluid balance (mL/24 h) 648±1676 1433±1713 <0.0001
Norepinephrine 11 (11) 31 (12) 0.74
Furosemide 5 (5) 38 (15) <0.001
24-hour ClCr - creatinine clearance calculated from the 24-hour collection of urine; estimated ClCr - creatinine clearance estimated from its plasma concentrations with the Cockcroft-Gault 
formula. Data are shown as number (%), mean±SD or median [IQR].
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Table 3 - Logistic regression analysis with renal hyperfiltration as the outcome 
variable
Independent variable OR 95%CI p value
Age (years) 0.946 0.932-0.961 <0.0001
Diabetes mellitus 0.337 0.123-0.923 0.034
OR - odds ratio; 95%CI - 95% confidence interval.
Forty-four patients received vancomycin, and 12 of 
them had ARC. These patients showed lower plasma 
concentrations of the drug and required higher doses 
than patients without ARC (Figure 2). After 24 hours 
of treatment, plasma concentrations of vancomycin were 
inversely correlated with 24-hour ClCr, and no patient 
with ARC reached the target through levels (Figure 3).
DISCUSSION
The analysis of this cohort of critically ill patients 
showed that ARC was a common finding, which was 
independently associated with age and absence of 
diabetes. In addition, the estimated ClCr frequently failed 
to diagnose ARC. The proper identification of ARC 
required the measurement of a 24-hour ClCr. Moreover, 
the presence of such a condition produced remarkable 
changes in vancomycin treatment.
Considerable controversies exist regarding the normal 
upper limit of the glomerular filtration rate. Although normal 
limits have been defined as 130 and 120mL/min/1.73m2 
for men and women, respectively,(2) values >120-130mL/
min/1.73m2, regardless of gender, have been used for the 
Figure 2 - Panel A) Plasma levels of vancomycin in patients with and without augmented renal clearance. Panel B) Doses of vancomycin in patients with and without 
augmented renal clearance. Data are shown as the mean±SD. p values are referred to the results of two-way repeated measures of ANOVA.
definition of increased renal clearance.(13,14) A classification 
system proposed values of ClCr >120mL/min/1.73m
2 in 
the elderly and >150mL/min/1.73m2 in young adults for 
the definition of hyperfiltration.(15) In this study, we chose 
a ClCr cutoff of 120mL/min/1.73m
2 for hyperfiltration, 
taking into account our predominantly old population 
(61±18 years).
In different groups of critically ill patients with 
normal plasma creatinine concentrations, several studies 
have shown that estimated and 24-hour ClCr have poor 
agreement, with the estimated ClCr being systematically 
lower than the 24-hour ClCr.
(3,16-23) In a group of 86 
critically ill patients with increased renal clearance, 
the sensitivity of estimated ClCr for the identification 
of ARC was only 62%.(3) In a retrospective study of 
390 postoperative patients with ARC, 95% limits of 
agreement between the 24-hour and estimated ClCr were 
wide (-131.7 to 109.3mL/min).(16) Our study showed not 
only wide limits of agreement (-69 to 82 mL/min) but also 
low sensitivity of estimated ClCr to diagnose ARC (39%). 
Thus, the correct identification of ARC should rely on 
measured instead of calculated ClCr. The use of measured 
ClCr is also emphasized because of its well-established 
correlation with drug elimination,(24,25) and the simplicity 
of urine collection in the ICU.
The incidence of ARC and its determinants has 
been studied previously. Most of the studies, however, 
were performed in particular clinical states such as 
trauma,(26,27) burns(5) and sepsis,(14,26,28) or in small series 
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Figure 3 - Relationship between plasma concentrations of vancomycin 24-hour 
urine-collected creatinine clearance after 24 hours from the beginning of the 
treatment. Dashed area is the targeted through concentration of vancomycin.
of patients.(5,13,27) In contrast, we studied a large cohort of 
critically ill patients admitted during a 1-year period to a 
mixed medical-surgical ICU, of whom 28% had augmented 
renal clearance on the first day of admission. Similarly, 
a retrospective analysis of 1317 patients admitted to a 
surgical ICU found a 24-hour ClCr >120mL/min/1.73m
2 
in 30% of the cases.(16) Higher incidences were reported 
in other investigations, but most included young patients. 
For example, Udy et al. reported increased renal clearance 
in 58% of septic and trauma patients, with a mean age 
of 42±17 years.(26) On the other hand, Fuster-Lluch et al. 
showed that 18% of patients with a median age of 61 years 
had ARC on ICU admission,(13) while Claus et al. found 
an incidence of 30% in septic patients, with a median age 
of 60 years.(28) These figures, quite dissimilar, could be 
related to the age of the populations studied.
Our results - along with those from other studies 
- suggest that ARC might be another expression of the 
response to critical illness, which can be fully manifested 
only in subjects with an adequate physiologic reserve, 
namely in young patients without comorbidities.
Our patients with ARC were younger, had trauma 
or obstetric admissions, and showed less cardiovascular 
comorbidities and diabetes, compared to those without 
ARC. Of these factors, only age and absence of diabetes 
were independently associated with the development 
of ARC. Young age is the most frequently described 
independent predictor.(26,28,29) Trauma is often reported as an 
independent determinant(26,29) and was not identified in our 
study possibly due to the small number of trauma patients 
included. Pregnancy is a well-known condition that induces 
hyperdynamic changes and ARC.(30) During early pregnancy, 
the glomerular filtration rate measured by inulin clearance 
increased 32% compared with the pre-pregnant value 
(from 115±18 to 150±23mL/min/1.73m2.(31) Although 
we found increased renal clearance more frequently in 
patients with obstetric admissions, multivariate analysis 
showed that this association was related to the younger age 
of pregnant women.
We found no differences in patients with and without 
ARC, in terms of volume of fluids infused and the use 
of norepinephrine. In spite of this, patients with ARC 
showed higher urinary output and electrolyte excretion, 
less positive fluid balance, and lower use of furosemide. 
These findings suggest that the development of ARC 
was not related to the resuscitation therapy and that the 
elimination of water and electrolytes was a consequence 
of ARC.
Patients with ARC had lower plasma concentrations 
of vancomycin during the first days of treatment, and no 
patient reached the targeted through level on the first day. 
This occurred regardless of increasing doses of vancomycin, 
which after 72 hours from the start of treatment were 
almost 50% higher than in patients without ARC. 
Moreover, at this time, mean plasma concentrations were 
under the lower limit of the suggested levels, implying 
that most patients with ARC were inappropriately treated. 
These results confirm the association between ARC and 
subtherapeutic serum vancomycin levels in critically ill 
patients.(14) The development of therapeutic failure of 
antibiotics has repeatedly been associated with the presence 
of increased ClCr.
(6-8,28) Because estimated ClCr has a poor 
sensitivity for the identification of ARC, these findings 
emphasize the need for monitoring both measured ClCr 
and plasma drug concentrations.
This study has some limitations: 1) The measurement 
of 24-hour ClCr is not the gold standard to measure 
glomerular filtration. The use of inulin or exogenous 
markers such as iothalamate and EDTA to assess 
renal function, might produce different results. Albeit 
tubular creatinine secretion at high filtration rates 
is improbable,(32) a study in pregnant women with 
increased glomerular filtration showed that the 24-hour 
ClCr underestimated inulin clearance.
(31) 2) ARC was only 
evaluated on ICU admission. A study showed that 18% 
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Objetivo: Foi descrito um incremento da depuração renal 
em alguns grupos de pacientes gravemente enfermos, o qual 
pode induzir à eliminação de concentrações de fármacos por 
filtração glomerular aquém do ideal, principalmente no caso de 
antibióticos. Sua ocorrência e os fatores determinantes têm sido 
pouco estudados. Nossos objetivos foram determinar a incidência e 
os fatores associados ao incremento da depuração renal, bem como 
seus efeitos nas concentrações e na posologia de vancomicina em 
uma série de pacientes em unidade de terapia intensiva.
Métodos: Estudamos, de forma prospectiva, 363 pacientes 
admitidos durante 1 ano em uma unidade de terapia intensiva 
clínico-cirúrgica. Foram excluídos pacientes que tivessem nível 
de creatinina sérica >1,3mg/dL. A depuração de creatinina foi 
calculada a partir da coleta de urina de 24 horas. Os pacientes 
foram agrupados segundo a presença de incremento da depuração 
renal (depuração de creatinina >120mL/min/1,73m2), e os 
possíveis fatores de risco foram analisados por meio de análise 
bivariada e logística. Em pacientes tratados com vancomicina, 
foram registradas a posologia e as concentrações plasmáticas.
Resultados: O incremento da depuração renal esteve presente 
em 103 pacientes (28%), os quais eram mais jovens (48±15 versus 
65±17 anos; p<0,0001), tinham mais frequentemente admissões 
obstétricas (16 versus 7%; p=0,0006) e por trauma (10 versus 
3%; p=0,016), e menos comorbidades. Os únicos determinantes 
independentes para o desenvolvimento de incremento da depuração 
renal foram idade (OR=0,95; IC95%=0,93-0,96; p<0,0001;) e 
ausência de diabetes (OR 0,34; IC95% 0,12-0,92; p=0,03). Doze 
dos 46 pacientes que receberam vancomicina tinham incremento da 
depuração renal e, apesar das doses elevadas, tinham concentrações 
plasmáticas de vancomicina mais baixas.
Conclusões: Nessa coorte de pacientes gravemente 
enfermos, foi frequente o achado de incremento da depuração 
renal. Idade e ausência de diabetes foram os únicos determinantes 
independentes. Assim, pacientes jovens e previamente saudáveis 
podem necessitar de doses mais elevadas de vancomicina.
RESUMO
Descritores: Creatinina; Vancomicina/uso terapêutico; 
Vancomicina/farmacocinética; Taxa de depuração metabólica; 
Sepse/quimioterapia
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